• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Basic Materials·4977.T
Share

Nitta Gelatin Inc. Stocks

¥ 1196Last Updated 16.10.2026

Issuer Rating

5/7
Performance

Strong

Risk

Moderate

Recommendation

Hold

Market Cap

¥ 134.33M

¥ 1196
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in Osaka, Japan, in 1918, Nitta Gelatin Inc. is a leading manufacturer and supplier primarily focused on gelatin and collagen products. The company's operations encompass the production and distribution of edible, pharmaceutical, and photographic gelatin, predominantly within the Japanese market. Utilizing raw materials like animal bones and skin, as well as fish scales and skin, they also develop a varied range of collagen-derived products. This includes industrial-grade gelatin for both food and pharmaceutical industries, alongside collagen peptides, which are known for their bioactive and bioregulatory characteristics, produced using proprietary proteolytic technology. Additionally, Nitta Gelatin provides other food ingredients and stabilizers vital for confectionery, desserts, delicatessen items, and chilled foods. They further extend their expertise to the medical field, supplying specialized collagen and medical gelatin to device manufacturers and research institutions for use as biomaterials in applications such as artificial skin and bone.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, underpriced

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 4977.T is 1400 and suggests 18.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.10.2026 22:53

The Nasdaq fell 2% during trading. Brent crude surpassed $109 per barrel for the first time in a month

16.10.2026 22:33

U.S. Treasuries are on track for their best week since February amid concerns about AI

16.10.2026 21:33

Chipmakers' stocks are heading toward their longest losing streak in 20 years. The Nasdaq lost 1%.

16.10.2026 20:51

The euro could break its five-week losing streak following statements by the head of the U.S. Federal Reserve

16.10.2026 20:11

CoreWeave's stock continued to fall. Huang and Wood were unable to sustain its rise

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026